Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance

Go back to Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance

Integra LifeSciences (IART) Tops Q4 EPS by 1c, Offers FY Guidance

February 25, 2016 5:05 PM EST

Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $241.2 million versus the consensus estimate of $241.11 million.

GUIDANCE:

Integra LifeSciences sees FY2016 EPS of $3.35-$3.50, versus the consensus of $3.43.... More